Myomo Q1 2024 GAAP EPS $(0.10), Inline, Sales $3.754M Miss $4.071M Estimate
Portfolio Pulse from Benzinga Newsdesk
Myomo reported Q1 2024 earnings with a GAAP EPS of $(0.10), meeting analyst estimates but with sales of $3.754M missing the $4.071M estimate. This represents a 9.09% improvement in EPS and an 8.91% increase in sales year-over-year.
May 08, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Myomo reported Q1 2024 earnings with EPS of $(0.10), matching estimates, and sales of $3.754M, missing the $4.071M forecast. Year-over-year, EPS improved by 9.09% and sales by 8.91%.
While Myomo met EPS estimates, the miss on sales forecasts could temper investor enthusiasm, leading to a neutral short-term impact. The year-over-year improvements in both EPS and sales indicate underlying growth, which could offset negative reactions to the sales miss.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100